 |
List
of Topics for Presentation
- Worldwide
Uses of NAT
- Blood
Banking in the 21st Century
- Transfusion
Transmission of Hepatitis A Virus
- Implications
of Nucleic Acid Technology (NAT) Testing for Transfusion Services
- The Threat
Posed by West Nile Virus (WNV) in the U.S. to Transfusion Recipients
- Update
on Transfusion Transmitted Infectious Diseases
- The Infectious
Risk of Blood Transfusion: Then, Now and Beyond
- Blood
Banking Tutorials
- Implementing
a Nucleic Acid Technology (NAT) Lab
- Incidence
of Mini-pool Hepatitis C Virus (HCV) NAT Negative, Single Unit NAT Positive
Blood Donations among Serological Positives (anti-HCV)
- Follow-up
of HCV RNA Positive, anti-HCV Negative Blood Donors
- Increased
Peripheral Blood Progenitor Cells in Trauma Patients
- Beyond
the "C" (Candidate non-A,B,C,D,E Viral Hepatitis Agents)
- Transfusion-Associated
Graft-versus-Host Disease (T-A-GVHD): Diagnosis and Prevention
- Transfusion-related
Acute Lung Injury (TRALI): Diagnosis and Prevention
- Appropriate
Uses of Blood and Blood Components
- Hepatitis
B Virus NAT Testing
- Why NAT?
- Hepatitis
B Virus (HBV) - Current Risk from Transfusion
- An Update
on vCJD
- Transfusion
Reactions
- Risks
of Transfusion from Infectious Agents
- Basic
Blood Banking I: Immunohematology and Components
- Basic
Blood Banking II: Transfusion Reactions and Transfusion Transmitted
Infection
- Case Studies
- Leukocytes
in Blood Transfusions: The Good, the Bad and the Ugly
- CMV "Safe"
Blood: Is There Such a Thing?
|
|
|
